{"url_path":"/sec/anip/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000054-index.html","accession_number":"0001023024-26-000054","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000054-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":149,"has_tables":true,"body_markdown":"Item 9.01Exhibits\n\n(d)Exhibits\n\nExhibit\nNo.Description\n\n99.1\n[Investor Presentation, dated May 2026](may2026anipcorporatepres.htm)\n\n104Cover Page Interactive Data File (embedded with the Inline XBRL document)\n\n*The information in Item 7.01 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDated: May 13, 2026ANI PHARMACEUTICALS, INC.\n\n  \n\nBy:/s/ Stephen P. Carey\n\nName:Stephen P. Carey\n\nTitle:Senior Vice President Finance and Chief Financial Officer"}